Login / Signup

Clinical trial: intra dermal hepatitis B vaccination with topical imiquimod versus intra muscular hepatitis B vaccination in patients with inflammatory bowel disease.

Kwan-Lung KoYuk-Fai LamKa-Shing CheungIvan Fan-Ngai HungWai-Keung Leung
Published in: Alimentary pharmacology & therapeutics (2022)
Intradermal hepatitis B vaccination with topical imiquimod pre-treatment is safe and offers superior seroprotection to conventional IM administration in patients with IBD.
Keyphrases
  • patients with inflammatory bowel disease
  • clinical trial
  • wound healing
  • randomized controlled trial
  • combination therapy
  • high intensity